Press Releases
 
Chronic Myelogenous Leukemia Treatment Market to bring in US$ 8,550.8 Million Revenue by 2026 End

Chronic Myelogenous Leukemia Treatment Market

, 16 January 2019 -- Chronic Myelogenous Leukemia Treatment Market report categorizes the global market by Treatment Type (Disease Specific Treatment), Distribution Channel (Hospital Pharmacies), Drug Type (Branded) & Geography.

Majorly, chronic myelogenous leukemia (CML) occurs in ######, however, it sometimes occurs in children as well. However, targeted drugs called Tyrosine-Kinase Inhibitors (TKIs) have been effective in providing long-term survival rates. Meanwhile, the Food and Drug Administration (FDA) has recently approved dasatinib (Sprycel) for the treatment of chronic myelogenous leukemia in children. As the chronic myeloid leukemia is more aggressive in younger patients, the approval of drugs can help in effective treatment.

Read Report Overview: https://www.transparencymarketresearch.com/chronic-myelogenous-leukemia-treatment-market.html

Some of the factors such as a rise in research and development in oncology sector, innovation in drug development, new products in the pipeline, and the establishment of novel therapies are resulting in the growth of the global chronic myelogenous leukemia market. However, the high cost of treatment is one of the biggest factor hampering the growth of the market.

Some of the key players included in the report are Novartis, Bristol Myers Squibb, Pfizer, Hoffman-LaRoche and Schering Plough, Teva Pharmaceutical, and Others. The key players are entering into the mergers and acquisitions, partnerships, for new product launches and to expand geographically.

As per the latest report by Transparency Market Research (TMR), the global chronic myelogenous leukemia market is expected to witness strong growth. The market is estimated to register 6.7% CAGR during the forecast period 2017-2026. It is also expected to reach US$ 8,550.8 million revenue by the end of 2026.

Perceive the Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=34940

The global chronic myelogenous leukemia market is segmented on the basis of drug type, treatment type, distribution channel, and region. Based on the drug type, the market segment includes generic and branded drug. Among these, Branded drugs are expected to account for highest revenue share. On the basis of treatment type, the segment includes symptomatic treatment and disease specific treatment. During the forecast period 2017-2026, disease specific treatment is expected to witness significant growth.

Based on the distribution channel, the market is categorized into specialty pharmacies, hospital pharmacies, and retail pharmacies. Hospital pharmacies are expected to be the largest distribution channel during the forecast period 2017-2026. Region-wise, the segmentation includes North America, Latin America, Europe, Japan, Asia Pacific Excluding Japan (APEJ), and the Middle East and Africa (MEA). North America is expected to remain dominant in the global chronic myelogenous leukemia market through 2026.

Chronic myelogenous leukemia is a type of blood cancer that cannot be cured with normal treatments. Hence, a new class of drugs known as Tyrosine-Kinase Inhibitors (TKIs) has been developed that is resulting in the more effective treatment of CML. These class of drugs is also known as BCR-ABL inhibitors. Imatinib, which is known as first generation TKI, is quickly becoming a standard treatment for chronic myelogenous leukemia. Meanwhile, Nilotinib is a second generation TKI which is being used by patients who are no longer able to respond to imatinib. TKIs are expensive, hence, generic imatinibs have also been introduced in various countries. The biggest restricting factor in the use of TKIs is the high cost of these drugs. TKIs, including imatinib drug, is effective at killing leukemic cells, but still is not able to kill the CML cells from which the disease is born. Hence, new research is also being carried out for more advanced and effective treatment.

Obtain the Brochure of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34940

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: https://www.transparencymarketresearch.com/

# # #


Submitted by hawer on Wednesday, 16 January 2019 at 11:20 PM
Category: Health Care & Medical
 
Related News

Molecular Imaging Devices Market Size to Observe Steady Growth
Friday, 19 Jul 2019

Urology Surgical Instruments Market: Current Trends & Opportunities by 2024
Friday, 19 Jul 2019

Consumer Oxygen Equipment Market Scope and Opportunities Analysis 2016 - 2024
Friday, 19 Jul 2019

Artificial Pancreas Device Systems Market Research Key Players, Industry Overview and Forecasts to 2
Friday, 19 Jul 2019

Cold Plasma Market Poised to Expand at a Robust Pace Over 2016 - 2026
Friday, 19 Jul 2019

Related Events

Neurology in Clinical Practice 2019
Thursday, 18 Jul 2019

Current Applications and Future of Artificial Intelligence in Cardiology
Friday, 19 Jul 2019

Oncology Review
Saturday, 20 Jul 2019

Mammary Carcinoma Update 2019 - A continuing education series from the MCI Academy
Saturday, 20 Jul 2019

Breast Imaging A to Z: How to Read Like (or Better Than) the Experts-Hawaii
Monday, 22 Jul 2019

Latest News

The way to Invest in WEED FROM ONLINE DISPENSARIES
Friday, 19 Jul 2019

Bongacams Tokens Hack 2019
Friday, 19 Jul 2019

Bambusfurnier – Bambus Fassadenelemente
Friday, 19 Jul 2019

China Nail Make-Up (Make-Up) Market Research Report to 2023
Friday, 19 Jul 2019

Aircraft Pumps Market Scenario Indicates Prime Trends & Growth Parameters, 2018-2027
Friday, 19 Jul 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Friday, 19 July 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Neurology in Clinical Practice 2019
  • Current Applications and Future of Artificial Intelligence in Cardiology
  • Oncology Review
  • Mammary Carcinoma Update 2019 - A continuing education series from the MCI Academy
  • Update in Orthpaedic Surgery Conference July 22-25, 2019 Grand Hyatt Kauai

  • Latest Jobs
    Sorry, there are currently no entries posted here.